Higher Distress Scores Linked With Lower Survival in Myeloma

With several new agents entering the treatment landscape, patients with multiple myeloma are facing different toxicity, financial, and psychological burdens. As a chronic disease, additional attention is needed to address these issues and improve patients’ overall quality of life, according to John Richter, M.D.

Read full article on